Reports on the plans of merger between Euro-centric stock exchanges, Easdaq and EURO.NM and its prospects for European biotechnology companies. Corporate profile of Easdaq and EURO.NM; Benefits from the merger; Differentiation in the listing requirements for Easdaq and EURO.NM in the size-of-company category.